Andreoli Federico, Del Rio Alberto
Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Alma Mater Studiorum, University of Bologna, Via S. Giacomo 14, 40126 Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Alma Mater Studiorum, University of Bologna, Via S. Giacomo 14, 40126 Bologna, Italy ; Institute of Organic Synthesis and Photoreactivity, National Research Council, Via P. Gobetti, 101 40129 Bologna, Italy.
Comput Struct Biotechnol J. 2015 May 7;13:358-65. doi: 10.1016/j.csbj.2015.04.007. eCollection 2015.
Growing evidences show that epigenetic mechanisms play crucial roles in the genesis and progression of many physiopathological processes. As a result, research in epigenetic grew at a fast pace in the last decade. In particular, the study of histone post-translational modifications encountered an extraordinary progression and many modifications have been characterized and associated to fundamental biological processes and pathological conditions. Histone modifications are the catalytic result of a large set of enzyme families that operate covalent modifications on specific residues at the histone tails. Taken together, these modifications elicit a complex and concerted processing that greatly contribute to the chromatin remodeling and may drive different pathological conditions, especially cancer. For this reason, several epigenetic targets are currently under validation for drug discovery purposes and different academic and industrial programs have been already launched to produce the first pre-clinical and clinical outcomes. In this scenario, computer-aided molecular design techniques are offering important tools, mainly as a consequence of the increasing structural information available for these targets. In this mini-review we will briefly discuss the most common types of known histone modifications and the corresponding operating enzymes by emphasizing the computer-aided molecular design approaches that can be of use to speed-up the efforts to generate new pharmaceutically relevant compounds.
越来越多的证据表明,表观遗传机制在许多生理病理过程的发生和发展中起着关键作用。因此,在过去十年中,表观遗传学研究发展迅速。特别是,组蛋白翻译后修饰的研究取得了非凡的进展,许多修饰已被表征并与基本生物学过程和病理状况相关联。组蛋白修饰是大量酶家族的催化结果,这些酶家族对组蛋白尾部的特定残基进行共价修饰。这些修饰共同引发了一个复杂且协同的过程,这对染色质重塑有很大贡献,并可能导致不同的病理状况,尤其是癌症。因此,目前有几个表观遗传靶点正在进行药物发现验证,并且已经启动了不同的学术和工业项目以产生首批临床前和临床结果。在这种情况下,计算机辅助分子设计技术提供了重要工具,这主要是由于这些靶点可获得的结构信息不断增加。在本综述中,我们将简要讨论已知的最常见组蛋白修饰类型和相应的作用酶,重点介绍有助于加速生成新的药学相关化合物的计算机辅助分子设计方法。